Current proposed mechanisms of action of intravenous immunoglobulins in inflammatory neuropathies.
Intravenous immunoglobulins (IVIg) have been shown in a number of trials, to be an effective treatment for the three main types of inflammatory neuropathies: Guillain-Barré Syndrome (GBS), chronic inflammatory demyelinating polyneuropathy (CIDP), and multifocal motor neuropathy (MMN). IVIg is thought to exert its immunomodulatory effects by affecting several components of the immune system including B-cells, T-cells, macrophages, complement, cytokines and cellular adhesion molecules. This article reviews the published evidence and the principal postulated mechanisms of action of intravenous immunoglobulins with special emphasis on inflammatory neuropathies.
Jacob
Saiju
S
Neuromuscular Clinic, Department of Neurology, University Hospitals of Leicester, United Kingdom.
Rajabally
Yusuf A
YA